CVRx (CVRX) Net Equity Issued and Repurchased (2024 - 2026)
CVRx's (CVRX) quarterly Net Equity Issued and Repurchased came in at -$43000.0 in Q1 2026, down 100.47% year-on-year from $9.2 million in Q1 2025, and up 75.98% quarter-over-quarter from -$179000.0 in Q4 2025.
CVRx (CVRX) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends
CVRx's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$43000.0 for Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased fell 100.47% year-over-year to -$43000.0 in Q1 2026; TTM through Mar 2026 was -$267000.0, a 100.65% decrease from a year earlier, with the FY2025 full-year figure at $9.0 million, down 72.41% from the prior year.
- Net Equity Issued and Repurchased grew to -$43000.0 in Q1 2026 per CVRX's latest filing, from -$179000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $19.6 million in Q3 2024 and bottomed at -$179000.0 in Q4 2025.
- The 3-year median for Net Equity Issued and Repurchased is $273000.0 (2024), against an average of $5.2 million.
- Biggest YoY gain for Net Equity Issued and Repurchased was 1581.54% in 2025; the steepest drop was 101.45% in 2025.
- Year by year, Net Equity Issued and Repurchased stood at $12.4 million in 2024, then plunged by 101.45% to -$179000.0 in 2025, then surged by 75.98% to -$43000.0 in 2026.
- Per Business Quant, the three latest CVRX Net Equity Issued and Repurchased figures stand at -$43000.0 (Q1 2026), -$179000.0 (Q4 2025), and -$45000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,000.00 |
| Mar 31, 2026 | -43,000.00 |
| Dec 31, 2025 | -179,000.00 |
| Dec 31, 2025 | -179,000.00 |
| Sep 30, 2025 | -45,000.00 |
| Sep 30, 2025 | -45,000.00 |
| Mar 31, 2025 | 9.20 Mn |
| Mar 31, 2025 | 9.20 Mn |
| Dec 31, 2024 | 12.35 Mn |
| Dec 31, 2024 | 12.35 Mn |
| Sep 30, 2024 | 19.62 Mn |
| Sep 30, 2024 | 19.62 Mn |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 547,000.00 |
| Mar 31, 2024 | 547,000.00 |